₩76,700+1.19%
2026-10-06 closeSK Biopharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was KRW 547.6B. 2024 operating profit was KRW 96.34B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy